Corona Remedies Limited (CORONA) Price & Analysis

― Followers

CORONA Stock Chart & Stats

$2068.00

$0.75(0.04%)

Jul 17, 2026

―

Day’s Range― - ―

52-Week Range$1,336.95 - $2,121.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₹126.48B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)68.3

Beta0.82

Next Earnings

Jan 01, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)7.40

Shares Outstanding61,160,088

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)41.07

Revenue Forecast (FY)₹16.51B

Corona Remedies Limited News

Corona Remedies Plans Singapore Non-Deal Roadshow for Investors

Corona Remedies Limited ( ($IN:CORONA) ) just unveiled an announcement. Corona Remedies Limited has announced that its officials...

2M ago

Corona Remedies Wins EU-GMP Nod for Hormone and OSD Facilities

Corona Remedies Limited ( ($IN:CORONA) ) has shared an announcement. Corona Remedies has secured European Union Good Manufacturing...

2M ago

CORONA FAQ

What was Corona Remedies Limited’s price range in the past 12 months?

Corona Remedies Limited lowest stock price was $1336.95 and its highest was $2121.00 in the past 12 months.

What is Corona Remedies Limited’s market cap?

Corona Remedies Limited’s market cap is ₹126.48B.

When is Corona Remedies Limited’s upcoming earnings report date?

Corona Remedies Limited’s upcoming earnings report date is Jan 01, 2027 which is in 166 days.

How were Corona Remedies Limited’s earnings last quarter?

Corona Remedies Limited released its earnings results on May 11, 2026. The company reported $7.4 earnings per share for the quarter, beating the consensus estimate of $7.1 by $0.3.

Is Corona Remedies Limited overvalued?

According to Wall Street analysts Corona Remedies Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Corona Remedies Limited pay dividends?

Corona Remedies Limited does not currently pay dividends.

What is Corona Remedies Limited’s EPS estimate?

Corona Remedies Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Corona Remedies Limited have?

Corona Remedies Limited has 61,160,088 shares outstanding.

What happened to Corona Remedies Limited’s price movement after its last earnings report?

Corona Remedies Limited reported an EPS of $7.4 in its last earnings report, beating expectations of $7.1. Following the earnings report the stock price went up 2.398%.

Which hedge fund is a major shareholder of Corona Remedies Limited?

Currently, no hedge funds are holding shares in IN:CORONA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology